Helen Louise Collins - Jul 28, 2021 Form 3 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Marc Grasso, Attorney-in-fact for Helen Collins
Stock symbol
KURA
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
3
Date filed
7/29/2021, 05:14 PM
Next filing
Jun 23, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.